» Articles » PMID: 32879056

Tumor Associated Mast Cells: Biological Roles and Therapeutic Applications

Overview
Journal Anat Cell Biol
Date 2020 Sep 4
PMID 32879056
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Mast cells (MCs) are immune cells of the myeloid lineage and are present in connective tissues throughout the body. The activation and degranulation of MCs significantly modulates many aspects of physiological and pathological conditions in various settings. Recent data have expanded the concept that inflammation is a critical component for tumor progression. Interestingly, three of the most aggressive human cancers, malignant melanoma, breast carcinoma and colorectal adenocarcinoma, are commonly associated with a marked host response comprising of various inflammatory cells, but especially MCs around the tumor periphery. A systematic review of the literature was performed based on the English titles listed in the PubMed, EBSCO, Cochrane, Science Direct, ISI web Science, and SciELO databases using the keywords. Abstracts and full-text articles were assessed. This review summarizes the current understanding of the role of MCs in tumor progression.

Citing Articles

Mast Cell Density in Squamous Cell Carcinoma of Skin in Dogs and Cats.

Juodziukyniene N, Lasiene K, Savickiene N, Aniuliene A Animals (Basel). 2025; 15(3).

PMID: 39943085 PMC: 11816034. DOI: 10.3390/ani15030316.


The Complex Role of Mast Cells in Head and Neck Squamous Cell Carcinoma: A Systematic Review.

Tzorakoleftheraki S, Koletsa T Medicina (Kaunas). 2024; 60(7.

PMID: 39064602 PMC: 11279237. DOI: 10.3390/medicina60071173.


Characteristics of mast cell infiltration in lung adenocarcinoma and its impact on prognosis.

Qiu Z, Pang G, Xu X, Lin J, Wang P Discov Oncol. 2024; 15(1):208.

PMID: 38834833 PMC: 11150364. DOI: 10.1007/s12672-024-01062-5.


The regulatory role and mechanism of mast cells in tumor microenvironment.

Ligan C, Ma X, Zhao S, Zhao W Am J Cancer Res. 2024; 14(1):1-15.

PMID: 38323271 PMC: 10839313.


Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer.

Zeng T, Yang G, Lou C, Wei W, Tao C, Chen X Nat Commun. 2023; 14(1):1340.

PMID: 36906670 PMC: 10008621. DOI: 10.1038/s41467-023-37030-w.


References
1.
Galli S . New concepts about the mast cell. N Engl J Med. 1993; 328(4):257-65. DOI: 10.1056/NEJM199301283280408. View

2.
Tan S, Fan Y, Luo H, Shen Z, Guo Y, Zhao L . Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. World J Gastroenterol. 2005; 11(8):1210-4. PMC: 4250716. DOI: 10.3748/wjg.v11.i8.1210. View

3.
Norrby K . Mast cells and de novo angiogenesis: Angiogenic capability of individual mast-cell mediators such as histamine, TNF, IL-8 and bFGF. Inflamm Res. 2016; 46(Suppl 1):7-8. DOI: 10.1007/PL00022372. View

4.
Kessler D, Langer R, Pless N, Folkman J . Mast cells and tumor angiogenesis. Int J Cancer. 1976; 18(5):703-9. DOI: 10.1002/ijc.2910180520. View

5.
Coussens L, Raymond W, Bergers G, Behrendtsen O, Werb Z, Caughey G . Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 1999; 13(11):1382-97. PMC: 316772. DOI: 10.1101/gad.13.11.1382. View